These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38159788)

  • 1. Correlation between high- and low-voltage impedance measurements following subcutaneous implantable cardioverter-defibrillator implantation.
    Sink J; Peigh G; Speakman B; Banno J; Sanders D; Nso N; Waits G; Lohrmann G; Elsayed M; Carneiro H; Baman J; Pfenniger A; Patil KD; Arora R; Kim SS; Chicos AB; Lin AC; Passman RS; Knight BP; Dandamudi S; Kaplan RM; Huang H; Wasserlauf J; Verma N
    Heart Rhythm; 2024 Apr; 21(4):492-494. PubMed ID: 38159788
    [No Abstract]   [Full Text] [Related]  

  • 2. Defibrillation testing of the subcutaneous implantable cardioverter-defibrillator at the time of generator replacement.
    Schaller RD; Hyman M; Supple GE; Santangeli P; Riley MP; Nazarian S; Arkles J; Garcia F; Lin D; Guandalini G; Kumareswaran R; Deo R; Bode W; Markman T; Epstein A; Callans DJ; Dixit S; Brozoski J; Marchlinski FE; Frankel DS
    Heart Rhythm; 2024 Jan; 21(1):117-118. PubMed ID: 37838309
    [No Abstract]   [Full Text] [Related]  

  • 3. Factors Associated With High-Voltage Impedance and Subcutaneous Implantable Defibrillator Ventricular Fibrillation Conversion Success.
    Amin AK; Gold MR; Burke MC; Knight BP; Rajjoub MR; Duffy E; Husby M; Stahl WK; Weiss R
    Circ Arrhythm Electrophysiol; 2019 Apr; 12(4):e006665. PubMed ID: 30917689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subcutaneous Implantable Cardioverter Defibrillator: Early Experience.
    Souza FSO; Matos VS; Almeida MCV; Weiss SC; Rodrigues LHB; Lima PAG; Mattos DB
    Braz J Cardiovasc Surg; 2017; 32(6):498-502. PubMed ID: 29267613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatal complications of pacemaker and implantable cardioverter-defibrillator implantation: medical malpractice?
    Schulz N; Püschel K; Turk EE
    Interact Cardiovasc Thorac Surg; 2009 Apr; 8(4):444-8. PubMed ID: 19168462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shoulder girdle function in patients with a subcutaneous implantable cardioverter-defibrillator.
    Zatorska-Berner M; Berner R; Janicki M; Strzelecki A; Cygankiewicz I; Wranicz JK; Kaczmarek K
    Kardiol Pol; 2024; 82(3):318-320. PubMed ID: 38230470
    [No Abstract]   [Full Text] [Related]  

  • 7. Safety and Feasibility Concerns of Radiotherapy in the Presence of Subcutaneous Implantable Cardioverter-Defibrillator.
    Tajstra M; Dyrbuś M; Stąpór-Fudzińska M; Rutkowski T; Gąsior M; Blamek S
    JACC Clin Electrophysiol; 2024 Mar; 10(3):581-582. PubMed ID: 38276926
    [No Abstract]   [Full Text] [Related]  

  • 8. Relationship of Shock Energy to Impedance During Subcutaneous Implantable Cardioverter-Defibrillator Testing.
    Payne JE; Badertscher P; Field ME; Sturdivant JL; Gold MR
    Circ Arrhythm Electrophysiol; 2020 Sep; 13(9):e008631. PubMed ID: 32703008
    [No Abstract]   [Full Text] [Related]  

  • 9. [Annual report 2017 of the German pacemaker- and defibrillator register - Part 2: implantable cardioverter defibrillators (ICD). : Working group on Cardiac pacemaker and implantable cardioverter-defibrillators at the IQTIG - Institute of Quality Assurance and Transparency in Healthcare].
    Markewitz A;
    Herzschrittmacherther Elektrophysiol; 2019 Dec; 30(4):389-403. PubMed ID: 31705261
    [No Abstract]   [Full Text] [Related]  

  • 10. Ask the doctor. I heard on the news that the pacemaker inside an implantable cardioverter/defibrillator (ICD) can damage the heart. Is that true?
    Lee TH
    Harv Heart Lett; 2003 Apr; 13(8):8. PubMed ID: 12711580
    [No Abstract]   [Full Text] [Related]  

  • 11. Low-voltage shock impedance measurements: A false sense of security.
    Parwani AS; Lacour P; Franke P; Reichert U; Christoph K; Beiert T; Supryn R; Rangasamy K; Kull T; Hohendanner F; Heinzel F; Kucher A; Boldt LH; Pieske B; Blaschke F
    Pacing Clin Electrophysiol; 2021 Jan; 44(1):93-100. PubMed ID: 33140439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High shock impedance during subcutaneous implantable defibrillator generator replacements.
    Maass AH; Groenveld HF; Mulder BA; Blaauw Y; Rienstra M
    Europace; 2022 Feb; 24(2):349-350. PubMed ID: 34626189
    [No Abstract]   [Full Text] [Related]  

  • 13. Inappropriate shock from a subcutaneous implantable cardioverter-defibrillator due to transcutaneous electrical nerve stimulation.
    Miller MA; Palaniswamy C; Sharma D; Reddy VY
    Heart Rhythm; 2015 Jul; 12(7):1702-3. PubMed ID: 25889810
    [No Abstract]   [Full Text] [Related]  

  • 14. [Annual report 2018 of the German pacemaker and defibrillator registry-part 2: implantable cardioverter-defibrillators : Working group on cardiac pacemakers and cardioverter-defibrillators at IQTIG-Institute for Quality Assurance and Transparency in Healthcare].
    Markewitz A;
    Herzschrittmacherther Elektrophysiol; 2021 Mar; 32(1):75-88. PubMed ID: 33275174
    [No Abstract]   [Full Text] [Related]  

  • 15. Current use of implantable electrical devices in Sweden: data from the Swedish pacemaker and implantable cardioverter-defibrillator registry.
    Gadler F; Valzania C; Linde C
    Europace; 2015 Jan; 17(1):69-77. PubMed ID: 25336667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High shock impedance during subcutaneous implantable defibrillator generator replacements: Authors' reply.
    van der Stuijt W; Smeding L; Knops RE
    Europace; 2022 Feb; 24(2):350-351. PubMed ID: 34626183
    [No Abstract]   [Full Text] [Related]  

  • 17. [Annual report 2019 of the German pacemaker and defibrillator registry-part 2: implantable cardioverter-defibrillators (ICD) : Working group on cardiac pacemakers and cardioverter-defibrillators at IQTIG-Institute for Quality Assurance and Transparency in Healthcare].
    Markewitz A;
    Herzschrittmacherther Elektrophysiol; 2021 Dec; 32(4):524-540. PubMed ID: 34328535
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute shock efficacy of the subcutaneous implantable cardioverter-defibrillator according to the implantation technique.
    Francia P; Adduci C; Angeletti A; Ottaviano L; Perrotta L; De Vivo S; Bongiorni MG; Migliore F; Russo AD; De Filippo P; Caravati F; Nigro G; Palmisano P; Viani S; D'Onofrio A; Lovecchio M; Valsecchi S; Ziacchi M
    J Cardiovasc Electrophysiol; 2021 Jun; 32(6):1695-1703. PubMed ID: 33969578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Moderate exercise training improves functional capacity, quality of life, and endothelium-dependent vasodilation in chronic heart failure patients with implantable cardioverter defibrillators and cardiac resynchronization therapy.
    Belardinelli R; Capestro F; Misiani A; Scipione P; Georgiou D
    Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):818-25. PubMed ID: 17001224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival in Women Versus Men Following Implantation of Pacemakers, Defibrillators, and Cardiac Resynchronization Therapy Devices in a Large, Nationwide Cohort.
    Varma N; Mittal S; Prillinger JB; Snell J; Dalal N; Piccini JP
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28490521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.